nerve regeneration program (Migragen/Morphochem)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenerve regeneration program (Migragen/Morphochem)
Drug Alias NameNGF agonists (Migragen/Morphochem)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsSpinal Cord InjuriesBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMigragen AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMigragen AG
Active IndicationsN/A
Inactive IndicationsSpinal Cord InjuriesBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A